Metraipolis › archive › dc_82ab12bf7897

Advances and Future Directions in Antibody-Drug Conjugates: From Paradigm Shifts to Data-Driven Design — Europe PMC PMID:42449646

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42449646
DOI
10.3390/cancers18132102
License (as archived)
solo-consultazione
Archived
2026-10-31T07:49:13.471Z
SHA-256 of the archived text
14189d57336926b0ac535898999d1185e4dc522d00a0f85a2da1c9a5d94b7bc5
Stable URL of this page
https://metraipolis.com/documento/dc_82ab12bf7897

How to cite

Advances and Future Directions in Antibody-Drug Conjugates: From Paradigm Shifts to Data-Driven Design — Europe PMC PMID:42449646 — Europe PMC (en), https://europepmc.org/article/MED/42449646 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_82ab12bf7897 (Metraipolis archive dc_82ab12bf7897, sha256 14189d57336926b0ac535898999d1185e4dc522d00a0f85a2da1c9a5d94b7bc5)
BibTeX
@misc{dc82ab12bf7897,
  title = {Advances and Future Directions in Antibody-Drug Conjugates: From Paradigm Shifts to Data-Driven Design — Europe PMC PMID:42449646},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42449646},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_82ab12bf7897; sha256 14189d57336926b0ac535898999d1185e4dc522d00a0f85a2da1c9a5d94b7bc5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42449646. Agents can read the archived copy with the MCP tool read_document.